Transparency Market Research in its new report titled, “Bacteremia Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2018 – 2026,” provides key insights on the bacteremia treatment market. The TMR report anticipates that the growing research and development to overcome drug resistance in bacteria and increasing awareness among end-users about rapid diagnosis of bacteremia to prevent mistreatment will drive the bacteremia treatment market during the forecast period i.e, 2018-2026. However, intense competition among major global manufacturers and domestic players is resulting in decrease in their profit margins. This is projected to hamper the global bacteremia treatment market from 2018 to 2026, says the report.
The TMR report has segmented the global bacteremia treatment market based on bacterial infection type, drug type, end-user, distribution channel, and region. Based on bacterial infection type, the global bacteremia treatment market is bifurcated into Gram-positive bacterial infection and Gram-negative bacterial infection. In terms of drug type, the global bacteremia treatment market is divided into antibiotics and vasopressors. The antibiotics segment can be sub-classified into quinolones, cephalosporin, penicillin, carbapenems, amebicides, and others. Antibiotics used in the treatment of bacteremia are exclusively delivered through the intravenous route of administration. Often, the combination treatment of antibiotics and vasopressors is employed for the treatment of bacteremia. Also, if the disease condition progresses to terminal stages, dialysis is also carried out along with external support for breathing. The oxygen supply boosts the health of patients by reducing strain on the lungs. In terms of end-user, the global bacteremia treatment market can be categorized into ambulatory surgical centers, hospitals, and clinics. The hospitals segment accounts for the maximum share of the market, owing to presence of skilled workforce and is projected to continue its dominance during the forecast period. Based on distribution channel, the global bacteremia treatment market can be segmented into hospital pharmacies and independent pharmacies & drug stores.
On a geographical standpoint, the global bacteremia treatment market is categorized into five major geographies: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The global bacteremia treatment market is anticipated to be dominated by North America during the forecast period, owing to availability of proper reimbursement structure, relatively high average selling prices of drugs, and established distribution network of major manufacturers in the region. However, the markets in developing countries such as China, India, and Brazil are projected to register an above-average growth rate, in terms of value, during the forecast period, primarily due to significant population of patients with chronic diseases, inconsistent treatment, increasing demand for affordable care, and strong emergence of local manufacturers. Major manufacturers are focused on tapping this lucrative opportunity for business expansion in developing countries through distribution agreements with domestic distributors. Prominent players operating in the global bacteremia treatment market include Merck & Co., Inc., Ronak Daru Co., Bayer AG, Pfizer Inc., Baxter, ANI Pharmaceuticals, Inc., Theravance Biopharma, Novartis AG, Fresenius SE & Co. KGaA, Mylan N.V., and Sun Pharmaceutical Industries Ltd.
About Us
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
